Risk perceptions and family history of lung cancer: Differences by smoking status

Public Health Genomics

Volumn 14, Issue 1, 2011, Pages 26-34

  Chen, L S ^a   Kaphingst, K A ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Family history; Lung cancer; Risk perceptions; Smoking

Indexed keywords

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEDICAL INFORMATION; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SAMPLE; SMOKING; SMOKING CESSATION;

EID: 78650415021     PISSN: 16624246     EISSN: None     Source Type: Journal    
DOI: 10.1159/000294151     Document Type: Article

References (47)

1. American Lung Association: Lung cancer fact sheet. 2007. Available at http://www. lungusa.org/site/apps/nlnet/content3.aspx? c=dvLUK9O0E&b= 4294229&ct=3232839.
2. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ: Can family history be used as a tool for public health and preventive medicine? Genet Med 2002; 4: 304-310.
3. Schwartz AG. Lung cancer: family history matters. Chest 2006; 130: 936-937.
4. Schwartz AG, Ruckdeschel JC: Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 16-22.
5. Thorne SL, Malarcher A, Maurice E, Caraballo R: Cigarette smoking among adults - United States, 2007. MMWR 2008; 57: 1221-1226.
6. McBride CM, Bepler G, Lipkus IM, Lyna P, Samsa G, Albright J, Datta S, Rimer BK: Incorporating genetic susceptibility feedback into a smoking cessation program for African- American smokers with low income. Cancer Epidemiol Biomarkers Prev 2002; 11: 521-528.
7. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J: Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 2008; 13: 481-494.
8. Lerman C, Gold K, Audrain J, Lin TH, Boyd NR, Orleans CT, Wilfond B, Louben G, Caporaso N: Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 1997; 16: 87-99.
9. Ito H, Matsuo K, Wakai K, Saito T, Kumimoto H, Okuma K, Tajima K, Hamajima N: An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med 2006; 42: 102-108.
10. Audrain J, Boyd NR, Roth J, Main D, Caporaso NF, Lerman C: Genetic susceptibility testing in smoking-cessation treatment: oneyear outcomes of a randomized trial. Addict Behav 1997; 22: 741-751.
11. Yoon PW, Scheuner MT, Khoury MJ: Research priorities for evaluating family history in the prevention of common chronic diseases Am J Prev Med 2003; 24: 128-135.
12. Matakidou A, Eisen T, Houlston RS: Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005; 93: 825-833.
13. Janz NK, Champion VL, Strecher VJ: The health belief model; in Glanz K, Rimer BK, Lewis FM (eds): Health Behavior and Health Education, ed 3. San Francisco, John Wiley & Sons Inc., 2002, pp 45-66.
14. Leventhal, H, Meyer, D, Nerenz, D: The common sense representation of illness danger; in Rachman, S. (ed): Contribution to Medical Psychology. Oxford, Pergamon Press, 1980, pp 7-30.
15. Rimal RN, Real K: Perceived risk and efficacy beliefs as motivators of change: use of the risk perception attitude (RPA) framework to understand health behaviors. Hum Commun Res 2003; 29: 370-399.
16. Rogers RW: A protection motivation theory of fear appeals and attitude change. J Psychol 1975; 91: 93-114.
17. Ajzen I, Fischbein M: Understanding Attitudes and Predicting Behavior. Englewood Cliffs, Prentice-Hall, 1980.
18. Witte K, Meyer G, Martell D: Effective Health Risk Messages: A Step-by-Step Guide. Thousand Oaks, Sage Publications Inc., 2001.
19. Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM: Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res 2006; 21: 740-749.
20. Bloom JR, Stewart SL, Oakley-Girvans I, Banks PJ, Chang S: Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev 2006; 15: 2167-2173.
21. Aiken LS, Fenaughty AM, West SG, Johnson JJ, Luckett TL: Perceived determinants of risk for breast cancer and the relations among objective risk, perceived risk, and screening behavior over time. Womens Health 1995; 1: 27-50.
22. Evans DG, Burnell LD, Hopwood P, Howell A: Perception of risk in women with a family history of breast cancer. Br J Cancer 1993; 67: 612-614.
23. Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, Murday V, Sacks N, Eeles R: Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998; 35: 731-738.
24. Mouchawar J, Byers T, Cutter G, Dignan M, Michael S: A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites. Cancer Detect Prev 1999; 23: 22-30.
25. Lipkus IM, Kuchibhatla M, McBride CM, Bosworth HB, Pollak KI, Siegler IC, Rimer BK: Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev 2000; 9: 973-975.
26. Orom H, Cote ML, Gonzalez HM, Underwood W, 3rd, Schwartz AG: Family history of cancer: is it an accurate indicator of cancer risk in the immigrant population? Cancer 2008; 112: 399-406.
27. Weinstein ND, Marcus SE, Moser RP: Smokers' unrealistic optimism about their risk. Tob Control 2005; 14: 55-59.
28. McCoy SB, Gibbons FX, Reis TJ, Gerrard M, Luus CA, Sufka AV: Perceptions of smoking risk as a function of smoking status. J Behav Med 1992; 15: 469-488.
29. National Cancer Institute: HINTS. 2007. Available at http://hints.cancer. gov/.
30. Morton TA, Duck JM: Communication and health beliefs: mass and interpersonal influences on perceptions of risk to self and others. Communication Research 2001; 28: 602-626.
31. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, John Wiley & Sons Inc., 2000.
32. Maldonado G, Greenland S: Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138: 923-936.
33. Budtz-Jorgensen E, Keilding N, Grandjean P, Weihe P: Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure. Ann Epidemiol 2007; 17: 27-35.
34. Weinstein ND: Accuracy of smokers' risk perceptions. Ann Behav Med 1998; 20: 135-140.
35. National Human Genome Research Institute: Family history initiative. 2007, Available at, http://www.genome.gov/17516481.
36. The Centers for Disease Control and Prevention: Family history public health initiative. 2007. Available at http://www.cdc.gov/ genomics/famhistory/ famhist.htm.
37. Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ: Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006; 8: 571-575.
38. Guttmacher AE, Collins FS, Carmona RH: The family history - more important than ever. N Engl J Med 2004; 351: 2333-2336.
39. The Surgeon General: My family health portrait. 2009. Available at https://familyhistory. hhs.gov/fhh-web/home.action.
40. Khoury MJ, Burke W, Thomson EJ: Genetics and Public Health in the 21st Century. New York, Oxford University Press, 2000.
41. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS: Genome- wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622.
42. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia- Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcatova I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633-637.
43. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsater A, Flex A, Aben KK, de Vegt F, Mulders PF, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642.
44. 23andMe: Genetics just got personal. 2008. Available at https://www.23andme.com.
45. Marcy TW, Stefanek M, Thompson KM: Genetic testing for lung cancer risk: if physicians can do it, should they? J Gen Intern Med 2002; 17: 946-951.
46. Liu JT, Hsieh CR: Risk perception and smoking behavior: evidence from Taiwan. J Risk Uncertain 1995; 11: 139-157.
47. Magnan RE, Köblitz AR, Zielke DJ, McCaul KD: The effects of warning smokers on perceived risk, worry, and motivation to quit. Ann Behav Med 2009; 37: 46-57.